INPLASY2024110045

Comprehensive evaluation of efficacy and safety in emerging first-line immunotherapies for advanced hepatocellular carcinoma: A systematic review and network meta-analysis

Keywords: advanced hepatocellular carcinoma; immunotherapy; camrelizumab plus apatinib; sintilimab plus bevacizumab; nivolumab plus ipilimumab.

Review Status: ongoing